Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

European Society for Cardiology logo - a stylised heart image drawing with 'European Society of Cardiology' wording alongside

The European Society of Cardiology Conference 2022 took place Friday 26 - Monday 29 August this year, and RDM researchers had a strong presence at the meeting, with a number of awards and key lectures. 

These include:

- Professor Stefan Neubauer, who gave the ESC Paul Hugenholtz Award lecture on Innovation, for which he received the ESC silver medal. 

Dr Marco Spartera won the Young Investigator Award. Dr Spartera said "This award gives us great pride and recognises the importance of ongoing research into novel mechanisms of cardiac embolism."

- Dr Robert Scarsini, a fellow in the Adrian Banning lab from 2019-21, also won a Young Investigator Award. 

- Professor Hugh Watkins gave a presentation on winning the British Heart Foundation's Big Beat Challenge

- Associate Professor Betty Raman gave an invited talk on 'Post-COVID syndrome with a cardiovascular focus'. 

- Dr Shveta Monga's DPhil project, entitled 'Metabolic Phenotypic in Aortic Stenosis: Insights from a multi-parametric CMR study' was selected for moderated posted presentation. 

Many congratulations to all!

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

New heart disease calculator could save lives by identifying high-risk patients missed by current tools

Collaborative research, led from NDPCHS and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.